Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma

PLoS Genetics

Volumn 12, Issue 9, 2016, Pages

  Haney, Staci L ^a   Upchurch, G Michael ^a   Opavska, Jana ^a   Klinkebiel, David ^b   Hlady, Ryan A ^c   Roy, Sohini ^b   Dutta, Samikshan ^b   Datta, Kaustubh ^b   Opavsky, Rene ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA; DNA METHYLTRANSFERASE 3A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN P53; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DNMT3A GENE; DOWN REGULATION; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENOME ANALYSIS; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE TRANSFORMATION; MOUSE; MOUSE MODEL; NONHUMAN; PERIPHERAL T CELL LYMPHOMA; PROMOTER REGION; PROTEIN FUNCTION; T-CELL LYMPHOMA CELL LINE; THYMOCYTE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84990184432     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006334     Document Type: Article

References (56)

1. Okano M, Bell DW, Haber DA, Li E, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell1999;99: 247–257. 10555141
2. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2003;33: 61–65. 12496760
3. Pradhan S, Bacolla A, Wells RD, Roberts RJ, Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J Biol Chem. 1999;274: 33002–33010. 10551868
4. Jeong M, Sun D, Luo M, Huang Y, Challen GA, Rodriguez B, et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nature Genet. 2014;46: 17–23. 24270360doi: 10.1038/ng.2836
5. Peters SL, Hlady RA, Opavska J, Klinkebiel D, Novakova S, Smith LM, et al. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T cell lymphomas. Mol Cell Biol. 2013;33: 4321–4333. doi: 10.1128/MCB.00776-1324001767
6. Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J, et al. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. J Clin Invest. 2012;122: 163–177. doi: 10.1172/JCI5729222133874
7. Haney SL, Hlady RA, Opavska J, Klinkebiel D, Pirruccello SJ, Dutta S, et al. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T cell lymphomagenesis. Oncogene2015;34: 5436–5446. doi: 10.1038/onc.2014.47225639876
8. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al. DNMT3A mutations in acute myeloid leukemia. New Engl J Med. 2010;363: 2424–2433. doi: 10.1056/NEJMoa100514321067377
9. Yang L, Rau R, Goodell MA, DNMT3A in hematological malignancies Nat. Rev Cancer2015;15: 152–165. doi: 10.1038/nrc389525693834
10. Bröske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet. 2009;41: 1207–1215. doi: 10.1038/ng.46319801979
11. Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011;44: 23–31. doi: 10.1038/ng.100922138693
12. Challen GA, Sun D, Mayle A, Jeong M, Luo M, Rodriguez B, et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell2014;15: 350–364. doi: 10.1016/j.stem.2014.06.01825130491
13. Mayle A, Yang L, Rodriguez B, Zhou T, Chang E, Curry CV, et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood2015;125: 629–638. 25416277
14. Celik H, Mallaney C, Kothari A, Ostrander EL, Eultgen E, Martens A, et al. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Blood2015;125: 619–628. 25416276
15. Guryanova OA, Lieu YK, Garrett-Bakelman FE, Spitzer B, Glass JL, Shank K, et al. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells. Leukemia. 2016;30:1133–1142. doi: 10.1038/leu.2015.35826710888
16. Peters SL, Hlady RA, Opavska J, Klinkebiel D, Pirruccello SJ, Talmon GA, et al. Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis. Leukemia. 2014;28: 1138–1142. doi: 10.1038/leu.2013.36424292811
17. Haney SL, Upchurch GM, Opavska J, Klinkebiel D, Hlady RA, Suresh A, et al. Promoter hypomethylation and expression is conserved in mouse chronic lymphocytic leukemia induced by decreased or inactivated Dnmt3a. Cell Reports. 2016;15:1190–1201. doi: 10.1016/j.celrep.2016.04.00427134162
18. Hirst M, Marra MA, Next generation sequencing based approaches to epigenomics. Brief Funct Genomics. 2010;9: 455–465. doi: 10.1093/bfgp/elq03521266347
19. Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. 2015;126, 1741–1752. 26268241doi: 10.1182/blood-2015-05-644591
20. van der Weyden L, Rust AG, McIntyre RE, Robles-Espinoza CD, del Castillo Velasco-Herrera M, Strogantsev R, et al. Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity. Oncogene2013;32: 397–402. doi: 10.1038/onc.2012.5622370638
21. Talos F, Petrenko O, Mena P, Moll UM, Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res. 2005;65:9971–9981. doi: 10.1158/0008-5472.CAN-05-108416267022
22. Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, et al. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015;47:1426–1434. doi: 10.1038/ng.344426551670
23. Piccaluga PP, Rossi M, Agostinelli C, Ricci F, Gazzola A, Righi S, et al. Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. Leukemia. 2014;28:1687–1697. doi: 10.1038/leu.2014.5024480986
24. Kovacic B, Stoiber D, Moriggl R, Weisz E, Ott RG, Kreibich R, et al. STAT1 acts as a tumor promoter for leukemia development. Cancer Cell. 2006;10:77–87. doi: 10.1016/j.ccr.2006.05.02516843267
25. Su X, Wang J, Chen W, Li Z, Fu X, Yang A, Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. Oncotarget. 2016;7:9939–9950. doi: 10.18632/oncotarget.694126799420
26. Piu F, Aronheim A, Katz S, Karin M, AP-1 Repressor Protein JDP-2: Inhibition of UV-Mediated Apoptosis through p53 Down-Regulation. Mol Cell Biol. 2001; 21: 3012–3024. doi: 10.1128/MCB.21.9.3012–3024.2001. PMCID: PMC86930 11287607
27. Bitton-Worms K, Pikarsky E, Aronheim A, The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice. Mol Cancer2010;9: 54. doi: 10.1186/1476-4598-9-5420214788
28. Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M, et al. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci USA2002;99: 11293–11298. 12151601
29. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA, JrPark SH, et al. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog. 1995;14:16–22. 7546219
30. Kato K, Oh Y, Takita J, Gunji Y, Kobayashi C, Yoshimi A, et al. Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma. Int J Hematol. 2016;103:196–201. 26676804doi: 10.1007/s12185-015-1895-9
31. Hollander MC, Patterson AD, Salvador JM, Anver MR, Hunger SP, Fornace AJ, Gadd45a acts as a modifier locus for lymphoblastic lymphoma. Leukemia. 2005;19:847–850. doi: 10.1038/sj.leu.240371115744335
32. Hodson DJ, Janas ML, Galloway A, Bell SE, Andrews S, Li CM, et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol. 2010;11:717–724. doi: 10.1038/ni.190120622884
33. Malik D, Kaul D, Chauhan N, Marwaha RK, miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T -cell pediatric acute lymphoblastic leukemias. Mol Cancer. 2014;13:175. doi: 10.1186/1476-4598-13-175. PMCID: PMC4112645 25037230
34. Li W, Jiang Z, Li T, Wei X, Zheng Y, Wu D, et al. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes. Mol Cancer. 2015;14:26. doi: 10.1186/s12943-014-0285-x25644173
35. Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez Mdel C, et al. 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia. Blood2002;99: 2291–2296. 11895758
36. Herman JA, Civin CI, Issa JJ, Collector MI, Sharkis SJ, Baylin SB, Distinct Patterns of Inactivation of p15INK4B and p16INK4A characterize the Major Types of Hematological Malignancies. Cancer Research. 1997;57: 837–841. 9041182
37. Roy D, Sin SH, Damania B, Dittmer DP, Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood. 2011;118:32–39. 21685375
38. Toujani S, Dessen P, Ithzar N, Danglot G, Richon C, Vassetzky Y, et al. High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma. PLoS One. 2009;4;e7089. doi: 10.1371/journal.pone.000708919759907
39. Fong LY, Fidanza V, Zanesi N, Lock LF, Siracusa LD, Mancini R, et al. Muir-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci U S A. 2000;97:4742–4747. doi: 10.1073/pnas.08006349710758156
40. Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, Boles KS, et al. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med. 2008;205: 2965–2973. doi: 10.1084/jem.2008175219029380
41. Ariës IM, Jerchel IS, van den Dungen RE, van den Berk LC, Boer JM, Horstmann MA, et al. EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion. Leukemia2014;28: 1828–1837. doi: 10.1038/leu.2014.8024625531
42. Xie L, Green PL, Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T cell leukemia virus type 1 (HTLV-1) and HTLV-2. J Virol. 2005;79:14536–14545. 16282453
43. Ye J, Xie L, Green PL, 2003. Tax and overlapping Rex sequences do not confer the distinct transformation tropisms of HTLV-1 and HTLV-2. J Virol. 2003;77: 7728–7735. 12829812
44. Hervouet E, Vallette FM, Cartron PF, Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics. 2009;4:487–499. 19786833
45. Krueger F, Andrews SR, Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics2011;27: 1571–1572. doi: 10.1093/bioinformatics/btr16721493656
46. Assenov Y, Müller F, Lutsik P, Walter J, Lengauer T, Bock C, Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods. 2014;11: 1138–1140. doi: 10.1038/nmeth.311525262207
47. Wu H, Xu T, Feng H, Chen L, Li B, Yao B, et al. Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates. Nucleic Acids Res. 2015;43: e141. doi: 10.1093/nar/gkv71526184873
48. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19: 1639–1645. doi: 10.1101/gr.092759.10919541911
49. Smit AFA. "RepeatMasker." URL: http://www.repeatmasker.org (1996–2005)
50. Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, Chromatin state dynamics during blood formation. Science. 2014; 345:943–949. 25103404doi: 10.1126/science.1256271
51. Quinlan AR, Hall IM, BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (Oxford, England). 2010;26:841–842.
52. Daily K, Patel VR, Rigor P, Xie X, Baldi P, MotifMap: integrative genome-wide maps of regulatory motif sites for model species. BMC Bioinformatics. 2011;12: 495. doi: 10.1186/1471-2105-12-49522208852
53. Xie X, Rigor P, Baldi P, MotifMap: a human genome-wide map of candidate regulatory motif sites. Bioinformatics. 2009;25:167–174. doi: 10.1093/bioinformatics/btn60519017655
54. Sun Z, Baheti S, Middha S, Kanwar R, Zhang Y, Li X, et al. SAAP-RRBS: streamlined analysis and annotation pipeline for reduced representation bisulfite sequencing. Bioinformatics2012;28: 2180–2181. doi: 10.1093/bioinformatics/bts33722689387
55. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36. doi: 10.1186/gb-2013-14-4-r3623618408
56. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L, Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013;31:46–53. doi: 10.1038/nbt.245023222703